| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVITED REVIEWS
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada
In patients with diabetes, an increased risk of symptomatic heart failure usually develops in the presence of hypertension or ischemic heart disease. However, a predisposition to heart failure might also reflect the effects of underlying abnormalities in diastolic function that can occur in asymptomatic patients with diabetes alone (termed diabetic cardiomyopathy). Evidence of cardiomyopathy has also been demonstrated in animal models of both Type 1 (streptozotocin-induced diabetes) and Type 2 diabetes (Zucker diabetic fatty rats and ob/ob or db/db mice). During insulin resistance or diabetes, the heart rapidly modifies its energy metabolism, resulting in augmented fatty acid and decreased glucose consumption. Accumulating evidence suggests that this alteration of cardiac metabolism plays an important role in the development of cardiomyopathy. Hence, a better understanding of this dysregulation in cardiac substrate utilization during insulin resistance and diabetes could provide information as to potential targets for the treatment of cardiomyopathy. This review is focused on evaluating the acute and chronic regulation and dysregulation of cardiac metabolism in normal and insulin-resistant/diabetic hearts and how these changes could contribute toward the development of cardiomyopathy.
heart disease; diabetes; insulin resistance; lipoprotein lipase; fatty acid transporters; PPARs; lipotoxicity; mitochondria dysfunction
This article has been cited by other articles:
|
|
 |
|
  M. S. Kim, F. Wang, P. Puthanveetil, G. Kewalramani, S. Innis, L. Marzban, S. F. Steinberg, T. D. Webber, T. J. Kieffer, A. Abrahani, et al. Cleavage of Protein Kinase D After Acute Hypoinsulinemia Prevents Excessive Lipoprotein Lipase-Mediated Cardiac Triglyceride Accumulation Diabetes, November 1, 2009; 58(11): 2464 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Sartoretto, B. Y. Jin, M. Bauer, F. B. Gertler, R. Liao, and T. Michel Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1697 - H1710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-F. Yeih, H.-I Yeh, H.-T. Hsin, L.-Y. Lin, F.-T. Chiang, C.-D. Tseng, S.-H. Chu, and Y.-Z. Tseng Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: role of myosin heavy chain isozyme Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1411 - H1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bugger and E. D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech., September 1, 2009; 2(9-10): 454 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Radovits, S. Korkmaz, S. Loganathan, E. Barnucz, T. Bomicke, R. Arif, M. Karck, and G. Szabo Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H125 - H133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Serpillon, B. C. Floyd, R. S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M. S. Wolin, and S. A. Gupte Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H153 - H162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Niu and R. D. Evans Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes J. Physiol., July 1, 2009; 587(13): 3301 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Boardman, A. D. Hafstad, T. S. Larsen, D. L. Severson, and E. Aasum Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1373 - H1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, M. S. Kim, P. Puthanveetil, G. Kewalramani, S. Deppe, S. Ghosh, A. Abrahani, and B. Rodrigues Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1108 - H1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, L. Ebermann, A. Sterner-Kock, S. Wika, H.-P. Schultheiss, A. Dörner, and T. Walther Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice Exp Physiol, February 1, 2009; 94(2): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Dabkowski, C. L. Williamson, V. C. Bukowski, R. S. Chapman, S. S. Leonard, C. J. Peer, P. S. Callery, and J. M. Hollander Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H359 - H369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Niu and R. D. Evans Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1106 - E1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-C. Yu, C.-K. Chang, H.-Y. Ou, K.-C. Cheng, and J.-T. Cheng Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats Cardiovasc Res, October 1, 2008; 80(1): 78 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kim, F. Wang, P. Puthanveetil, G. Kewalramani, E. Hosseini-Beheshti, N. Ng, Y. Wang, U. Kumar, S. Innis, C. G. Proud, et al. Protein Kinase D Is a Key Regulator of Cardiomyocyte Lipoprotein Lipase Secretion After Diabetes Circ. Res., August 1, 2008; 103(3): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Hruz, Q. Yan, H. Struthers, and P. Y. Jay HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy FASEB J, July 1, 2008; 22(7): 2161 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kewalramani, P. Puthanveetil, M. S. Kim, F. Wang, V. Lee, N. Hau, E. Beheshti, N. Ng, A. Abrahani, and B. Rodrigues Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E137 - E147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-F. Yeih, L.-Y. Lin, H.-I Yeh, Y.-J. Lai, F.-T. Chiang, C.-D. Tseng, S.-H. Chu, and Y.-Z. Tseng Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H867 - H874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Witteles and M. B. Fowler Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options J. Am. Coll. Cardiol., January 15, 2008; 51(2): 93 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Ruberg Myocardial Lipid Accumulation in the Diabetic Heart Circulation, September 4, 2007; 116(10): 1110 - 1112. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Marsh, P. C. Powell, A. Agarwal, L. J. Dell'Italia, and J. C. Chatham Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H292 - H298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Boudina and E. D. Abel Diabetic Cardiomyopathy Revisited Circulation, June 26, 2007; 115(25): 3213 - 3223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Hafstad, A. M. Khalid, O.-J. How, T. S. Larsen, and E. Aasum Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1288 - E1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yue, T. Arai, M. Terashima, A. Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R. C. Robbins, E. A. Ashley, J. Wu, et al. Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2106 - H2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shiojima and K. Walsh Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway Genes & Dev., December 15, 2006; 20(24): 3347 - 3365. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
